Antimicrobial stewardship in UK special care baby units: gaps in research and future directions
JAC-Antimicrobial Resistance · 02.07.2026 · 8 (4)
DOI: 10.1093/jacamr/dlag137 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 17.07.2026. Verfasst von Amedine Duret und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Paediatric Infectious Diseases, Department of Infection, Imperial College London, London, UK. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, NIHR Imperial Biomedical Research Centre, Wellcome.
Abstract (Originalsprache)
Despite a significant decline in the incidence of neonatal sepsis, the clinical imperative to avoid missing life-threatening infection continues to drive widespread antibiotic overprescription. Antimicrobial stewardship is universally recognized and explicitly mandated within the UK 2024–2029 National Action Plan on Antimicrobial Resistance as a critical mechanism to combat resistance and prevent iatrogenic harms related to infant dysbiosis. However, a major misalignment exists within the current evidence base: most of the neonatal stewardship research is conducted in highly resourced, tertiary Neonatal Intensive Care Units (Level 3), even though most postnatal inpatient care occurs in Special Care Baby Units (Level 1) and Local Neonatal Units (Level 2). This Viewpoint explores the operational and structural barriers that limit the transferability of intensive-care stewardship models to lower-acuity settings, identifies key research gaps around baseline prescribing practices and multidisciplinary collaboration, and argues for the inclusion of Level 1 and 2 populations in future validation studies of emerging diagnostic tools for neonatal sepsis.
Autor:innen und Institutionen
- Section of Paediatric Infectious Diseases, Department of Infection, Imperial College London, London, UK.
- Department of Microbiology, Imperial College Healthcare NHS Trust, London, UK.
- The Health Research Unit Zimbabwe (THRU-Zim), Biomedical Research and Training Institute, Harare, Zimbabwe.
- Department of Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.
- Department of Infectious Diseases, Imperial College London, London, UK.
- Department of Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.
ORCID-Profile: Frances Davies, Felicity Fitzgerald, Mark Gilchrist
Förderung
- Wellcome Trust
- NIHR Imperial Biomedical Research Centre
- Wellcome
- CARP
- MRC
- UKRI
Zitieren
APA
Duret, A., Davies, F., Fitzgerald, F., Gilchrist, M., Rodrigues, C., Banerjee, J., Shivamurthappa, V., & Bennett, A. (2026). Antimicrobial stewardship in UK special care baby units: gaps in research and future directions. JAC-Antimicrobial Resistance, 8(4). https://doi.org/10.1093/jacamr/dlag137
Vancouver
Duret A, Davies F, Fitzgerald F, Gilchrist M, Rodrigues C, Banerjee J, et al. Antimicrobial stewardship in UK special care baby units: gaps in research and future directions. JAC-Antimicrobial Resistance. 2026;8(4). doi:10.1093/jacamr/dlag137
BibTeX
@article{Duret2026,
author = {Duret, Amedine and Davies, Frances and Fitzgerald, Felicity and Gilchrist, Mark and Rodrigues, Charlene and Banerjee, Jayanta and Shivamurthappa, Vijaykumar and Bennett, Aisleen},
title = {Antimicrobial stewardship in UK special care baby units: gaps in research and future directions},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {4},
doi = {10.1093/jacamr/dlag137}
}
EUVIMED